These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 6313398

  • 1. Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase.
    Norman JA, Ansell J, Phillips MA.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):107-12. PubMed ID: 6313398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP, Sutherland C, Scott-Woo GC.
    Biochem Pharmacol; 1988 Apr 15; 37(8):1569-80. PubMed ID: 2833901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
    Sharma RK, Wang JH, Wu Z.
    J Neurochem; 1997 Aug 15; 69(2):845-50. PubMed ID: 9231746
    [Abstract] [Full Text] [Related]

  • 6. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M, Eiki R, Osawa K, Nakanishi S, Kase H.
    Biochem J; 1996 May 15; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [Abstract] [Full Text] [Related]

  • 7. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM, Cysouw KJ, Verdouw PD.
    Biochem Pharmacol; 1985 Nov 01; 34(21):3837-43. PubMed ID: 2933041
    [Abstract] [Full Text] [Related]

  • 8. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE, Lakey T, Houslay MD.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4123-36. PubMed ID: 2480793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD, Lugnier C, Schott C, Catret M, Noguera MA, Anselmi E, D'Ocon P.
    Br J Pharmacol; 1992 Jun 15; 106(2):387-94. PubMed ID: 1327380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
    Psychoyos S, Bax M, Atkins C.
    Biochem Pharmacol; 1986 May 15; 35(10):1639-46. PubMed ID: 3011009
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of bovine brain cyclic nucleotide phosphodiesterase by a proteinaceous factor from Escherichia coli.
    Iwasa Y.
    Horm Metab Res; 1982 May 15; 14(5):265-7. PubMed ID: 6284629
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.
    Epstein PM, Fiss K, Hachisu R, Andrenyak DM.
    Biochem Biophys Res Commun; 1982 Apr 14; 105(3):1142-9. PubMed ID: 6284165
    [No Abstract] [Full Text] [Related]

  • 18. Stereoselective inhibition of calmodulin-dependent cAMP phosphodiesterase from bovine heart by (+)- and (-)-nimodipine.
    Schächtele C, Wagner B, Marmé D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 14; 335(3):340-3. PubMed ID: 3035384
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K, Matsuda Y, Kase H, Yamada K.
    Biochem Biophys Res Commun; 1984 Oct 30; 124(2):315-21. PubMed ID: 6093793
    [Abstract] [Full Text] [Related]

  • 20. KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.
    Nakanishi S, Osawa K, Saito Y, Kawamoto I, Kuroda K, Kase H.
    J Antibiot (Tokyo); 1992 Mar 30; 45(3):341-7. PubMed ID: 1374373
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.